Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of Oncology (VHIO), which forms part of the Vall d'Hebron Campus, underscore the ...
Introduction Refractory headache is a common and frequently disabling disorder, affecting 2–12 million patients each year in ...